Literature DB >> 1488881

Acquired dacryocystitis: microbiology and conservative therapy.

V Huber-Spitzy1, F J Steinkogler, E Huber, E Arocker-Mettinger, M Schiffbänker.   

Abstract

The dacryocystitis in adults is mainly caused by postsaccal stenosis of the lacrimal ducts. The banking up of the lacrimal fluid leads to an accumulation of germs and following infection. This report describes the clinical and microbiological findings in a large consecutive series of patients that presented at the outpatient clinic of the 2nd Department of Ophthalmology of the University of Vienna with the signs of acute, chronic recurrent or chronic infections of the lacrimal system between 1983 and the end of 1990. Within the bacterial genus Staphylococci (S. aureus, S. epidermidis and S. saprophyticus) were the most frequently isolated organisms (74 cultures = 50% out of samples with positive cultures). It was quite interesting that a significant number of gram-negative rods (37 = 25.5%) could be isolated. Of these microorganisms Escherichia coli was most frequently growing on special media (17 cases = 11.7%) when cultures were obtained from acute inflamed lacrimal sacs of patients who suffered from chronic recurrent infections. Conservative therapy of purulent dacryocystitis constitutes the last possible preparation for a necessary surgical intervention and therefore the authors want to point out the importance of microbiological examinations so as to optimize antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1488881     DOI: 10.1111/j.1755-3768.1992.tb04880.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  11 in total

1.  Bacteriology of lacrimal duct obstruction in adults.

Authors:  J Hartikainen; O P Lehtonen; K M Saari
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

2.  Dacryocystitis: Systematic Approach to Diagnosis and Therapy.

Authors:  Sergio Pinar-Sueiro; Mercedes Sota; Telmo-Xabier Lerchundi; Ane Gibelalde; Bárbara Berasategui; Begoña Vilar; Jose Luis Hernandez
Journal:  Curr Infect Dis Rep       Date:  2012-01-29       Impact factor: 3.725

3.  Microbiologic spectrum of acute and chronic dacryocystitis.

Authors:  Bahram Eshraghi; Parisa Abdi; Mohammadreza Akbari; Masoud Aghsaei Fard
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

4.  Pathological, immunohistochemical and microbiologicalal analysis of lacrimal sac biopsies in patients with chronic dacrocystitis.

Authors:  Rowayda Mahmoud Amin; Faten Aly Hussein; Hisham Farouk Idriss; Nesrine Fathy Hanafy; Dina Mohamed Abdallah
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

5.  Surgical outcomes in acute dacryocystitis patients undergoing endonasal endoscopic dacryocystorhinostomy with or without silicone tube intubation.

Authors:  Bo Yu; Yu Xia; Jia-Ying Sun; Qian Ye; Yun-Hai Tu; Guang-Ming Zhou; Wen-Can Wu
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

6.  The microbiological profile of lacrimal abscess: two decades of experience from a tertiary eye care center.

Authors:  Mohammad Javed Ali; Swapna R Motukupally; Surbhi D Joshi; Milind N Naik
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-07-27

7.  Frequency of Bacterial Samples from Patients with Chronic Acquired Nasolacrimal Duct Obstruction.

Authors:  Kourosh Shahraki; Ali Makateb; Keyvan Shirzadi; Keivan Khosravifard
Journal:  Med Arch       Date:  2016-12

Review 8.  The Pathogenesis of Staphylococcus aureus Eye Infections.

Authors:  Richard J O'Callaghan
Journal:  Pathogens       Date:  2018-01-10

9.  Microbiological study of dacryocystitis in northwest of Iran.

Authors:  Fatemeh Eslami; Hamid Reza Ghasemi Basir; Abbas Moradi; Shokoufe Heidari Farah
Journal:  Clin Ophthalmol       Date:  2018-09-25

10.  The microbiologic spectrum of dacryocystitis.

Authors:  Ban Luo; Mu Li; Nan Xiang; Weikun Hu; Rong Liu; Xiaoqin Yan
Journal:  BMC Ophthalmol       Date:  2021-01-11       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.